Long-term survival with consolidation intraperitoneal chemotherapy for patients with advanced ovarian cancer with pathological complete remission
- 1 November 2003
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 91 (2) , 341-345
- https://doi.org/10.1016/s0090-8258(03)00474-8
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Intraperitoneal Chemotherapy for Ovarian Carcinoma: Results of Long-Term Follow-UpJournal of Clinical Oncology, 2002
- Intravenous Chemotherapy, Early Debulking Surgery, and Consolidation Intraperitoneal Chemotherapy in Advanced Ovarian CarcinomaGynecologic Oncology, 2001
- Ten-year follow-up of ovarian cancer patients after second-look laparotomy with negative findingsObstetrics & Gynecology, 1999
- A Phase II Trial of Intraperitoneal Cisplatin and Etoposide as Consolidation Therapy in Patients with Stage II–IV Epithelial Ovarian Cancer Following Negative Surgical AssessmentGynecologic Oncology, 1998
- Intraperitoneal Chemotherapy in the Treatment of Ovarian CancerAnnals of Medicine, 1996
- Intraperitoneal cisplatin chemotherapy in ovarian carcinoma patients who are clinically in complete remissionGynecologic Oncology, 1992
- Sequential cisplatin-doxorubicin, early debulking surgery and intraperitoneal chemotherapy in advanced ovarian cancerEuropean Journal Of Cancer, 1992
- Survival after second-look laparotomy in advanced ovarian epithelial cancer: Study of 86 patientsEuropean Journal of Cancer and Clinical Oncology, 1989
- Recurrent disease after negative second-look laparotomy in stages III and IV ovarian carcinomaGynecologic Oncology, 1988
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958